Filing Details

Accession Number:
0001203311-12-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-26 18:44:01
Reporting Period:
2012-04-25
Filing Date:
2012-04-26
Filing Date Changed:
2012-04-26
Accepted Time:
2012-04-26 19:44:01
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1393945 C Thomas Reynolds 21823 30Th Drive Se
Bothell WA 98021
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2012-04-25 40,000 $8.24 71,073
Common Stock Disposition 2012-04-25 40,000 $19.75 31,073
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-04-25 40,000 $0.00 40,000 $8.24
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on November 8, 2011.
  2. Amount of securities beneficially owned following reported transactions includes 27,886 Restricted Stock Units subject to vesting.
  3. Shares shall vest at a rate of 25% on 3/19/07 and monthly thereafter until all the shares are fully vested on 3/19/11.

Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!

Billionaire Hedge Funds